Christian successively managed 4 subsidiaries of the Rhône-Poulenc Aventis group from 1987. In 2000, he co-founded the biotech Urogen, sold 7 years later to Pierre Fabre. He holds directorships in several French biotech and medtech such as Delpharm, Cytomix System or Watchfrog.